{ "items": [ "\n\n
\n \n\n \n \n \n \n Funding\n \n \n \n \n Kennedy\n \n \n\n \n\n\n
\n \n\n \n6 October 2021
\n \n \n \nInhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n29 September 2021
\n \n \n \nTonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n17 September 2021
\n \n \n \nThe Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n17 August 2021
\n \n \n \nBuilding work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.
\n \n\n \n \n\n \n\n \n \n \n \n Immunity and microbiome\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n16 August 2021
\n \n \n \nJethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n6 August 2021
\n \n \n \nAs part of the University of Oxford\u2019s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.
\n \n\n \n \n\n \n\n \n \n \n \n Inflammation biology\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n26 July 2021
\n \n \n \nResearchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.
\n \n\n \n \n\n \n\n \n \n \n \n Arthritis\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n15 July 2021
\n \n \n \nNew research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n25 June 2021
\n \n \n \nA new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n21 June 2021
\n \n \n \nPostdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n10 June 2021
\n \n \n \nA new study published in Circulation Research shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n7 June 2021
\n \n \n \nResearchers at the Kennedy Institute join a collaboration to find new \u2018drug-free\u2019 ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.
\n \n\n \n \n\n \n\n \n \n \n \n Inflammation biology\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n20 May 2021
\n \n \n \nResearchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n17 May 2021
\n \n \n \nProfessor Anjali Kusumbe and Professor Cyrus Cooper have been presented with research awards by the European Calcified Tissue Society (ECTS).
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n12 May 2021
\n \n \n \nProfessor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n4 May 2021
\n \n \n \nProfessor Michael Dustin and an international team of collaborators have been awarded a \u20ac10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n29 April 2021
\n \n \n \nRecognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n16 April 2021
\n \n \n \nOxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Hand\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n8 April 2021
\n \n \n \nThree NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.
\n \n\n \n \n\n \n\n \n \n \n \n Arthritis\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n11 March 2021
\n \n \n \nNew research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).
\n \n\n \n \n